-
Patient Rating
5.0 /5( out of 13 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy.September 15, 2024UH HOSPITALS AND CLINICSDr. Monique Cho is a compassionate, caring physician. She is a good listener, explains the answers to questions extremely well, and is at the top of the chart in her research, especially as it applies to older adults. She helps you get to the best physical condition you can be in if you follow her recommendations. I am so very thankful I found her when my kidneys were not functioning well, for she's given me hope that with good choices I can stabilize their function and remain at the stage I'm in for a longer time than if left on my own.
September 14, 2024UH HOSPITALS AND CLINICSI have had the opportunity to meet with Dr. Cho fir the last 6 years, she has always been very concerned with my care, and is extremely knowledgeable. I genuinely enjoy visits with Dr. Cho.
July 07, 2024UH HOSPITALS AND CLINICSDr. Cho is an educated MD who does everything in her power to help diagnose and treat whatever your issue is.
June 10, 2024UH HOSPITALS AND CLINICSDr Cho is a very thoughtful and kind physician. Her care team are so caring and organized it makes every visit a pleasure.
June 08, 2024UH HOSPITALS AND CLINICSI have such respect for Dr. Cho. She asked if I had any questions and explained everything so well. And she was so friendly. She made me feel very comfortable!
April 28, 2024UH HOSPITALS AND CLINICSDr. Cho was great!!! She explained things well and seem To really take an interest in me and my situation.
April 27, 2024UH HOSPITALS AND CLINICSDr Cho is a wonderful, caring professional.
April 23, 2024UH HOSPITALS AND CLINICSDr. Cho continues to be a doctor of excellence. She listens, she advises, she explains, and she goes the extra mile to make sure you leave her office with needed information and a positive outlook.
February 19, 2024UH HOSPITALS AND CLINICSDr. Cho is one the most knowledgeable and compassionate doctors I have been treated by.
-
Board Certification and Academic Information
Academic Departments Internal Medicine -Primary Academic Divisions Nephrology & Hypertension
Education history
Professional Other Training Program in Clinical Research - National Institutes of Health/Duke University School of Medicine Senior Clinical Fellow Kidney Disease Branch - National Institute of Diabetes and Digestive and Kidney Diseases Senior Clinical Fellow Fellowship Nephrology - University of Rochester Medical Center Fellow Internal Medicine - University of Rochester Medical Center Resident Internship General Internal Medicine - Rhode Island Hospital Intern Medicine - Geisel School of Medicine at Dartmouth M.D. Graduate Training Harvard Extension School Postbaccalaureate Studies Psychology - Cornell University B.A. Selected Publications
Journal Article
- Dolui S, Detre JA, Gaussoin SA, Herrick JS, Wang DJJ, Tamura MK, Cho ME, Haley WE, Launer LJ, Punzi HA, Rastogi A, Still CH, Weiner DE, Wright JT Jr, Williamson JD, Wright CB, Bryan RN, Bress AP, Pajewski NM, Nasrallah IM (2022). Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial. JAMA Neurol, 79(4), 380-389. (Read full article)
- Mehta RC, Cho ME, Cai X, Lee J, Chen J, He J, Flack J, Shafi T, Saraf SL, David V, Feldman HI, Isakova T, Wolf M, CRIC Study Investigators (2021). Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease. Kidney Int, 100(6), 1292-1302. (Read full article)
- Cho ME, Hansen JL, Peters CB, Cheung AK, Greene T, Sauer BC (2019). An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease. Kidney Int, 96(3), 750-760. (Read full article)
- Agarwal A, Cheung AK, Ma J, Cho M, Li M (2019). Effect of Baseline Kidney Function on the Risk of Recurrent Stroke and on Effects of Intensive Blood Pressure Control in Patients With Previous Lacunar Stroke: A Post Hoc Analysis of the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes). J Am Heart Assoc, 8(16), e013098. (Read full article)
- Upadhya B, Lovato LC, Rocco M, Lewis CE, Oparil S, Cushman WC, Kostis JB, Rodriguez CJ, Cho ME, Cloud LW, Rastogi A, Rosendorff C, Kitzman DW (2019). Heart failure prevention in older patients using intensive blood pressure reduction: Potential role of diuretics. JACC Heart Fail, 7(12), 1032-1041.
- Upadhya B, Rocco MV, Pajewski NM, Morgan T, Blackshear J, Hundley WG, Oparil S, Soliman EZ, Cohen DL, Hamilton CA, Cho ME, Kostis WJ, Papademetriou V, Rodriguez CJ, Raj DS, Townsend R, Vasu S, Zamanian S, Kitzman DW, SPRINT Research Group (2019). Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART. Hypertension, HYPERTENSIONAHA11913073. (Read full article)
- Cho ME, Craven TE, Cheung AK, Glasser SP, Rahman M, Soliman EZ, Stafford RS, Johnson KC, Bates JT, Burgner A, Taylor AA, Tamariz L, Tang R, Beddhu S, SPRINT Study ResearchGroup (2017). The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial). J Clin Hypertens (Greenwich), 19(11), 1152-1161. (Read full article)
- Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, Carson TY, Tamariz L, Ghazi L, Cho ME, Shapiro BP, He J, Fine LJ, Lewis CE, SPRINT Research Study Group (2017). Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial). Circulation, 136(5), 440-450. (Read full article)
- Chen X, Wei G, Jalili T, Metos J, Giri A, Cho ME, Boucher R, Greene T, Beddhu S (2016). The Associations of Plant Protein Intake With All-Cause Mortality in CKD. Am J Kidney Dis, 67(3), 423-30. (Read full article)
- Bhattacharyya N, Wiench M, Dumitrescu C, Connolly BM, Bugge TH, Patel HV, Gafni RI, Cherman N, Cho M, Hager GL, Collins MT (2012). Mechanism of FGF23 processing in fibrous dysplasia. J Bone Miner Res, 27(5), 1132-41. (Read full article)
- Chen X, Summers RM, Cho M, Bagci U, Yao J (2012). An automatic method for renal cortex segmentation on CT images: evaluation on kidney donors. Acad Radiol, 19(5), 562-70. (Read full article)
- Sharma K, Ix JH, Mathew AV, Cho M, Pflueger A, Dunn SR, Francos B, Sharma S, Falkner B, McGowan TA, Donohue M, Ramachandrarao S, Xu R, Fervenza FC, Kopp JB (2011). Pirfenidone for diabetic nephropathy. J Am Soc Nephrol, 22(6), 1144-51. (Read full article)
- Cho ME, Duan Z, Chamberlain CE, Reynolds JC, Ring MS, Mannon RB (2010). Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism. Transplant Proc, 42(9), 3554-8. (Read full article)
- Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA (2008). MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet, 40(10), 1175-84. (Read full article)
- Zhou H, Cheruvanky A, Hu X, Matsumoto T, Hiramatsu N, Cho ME, Berger A, Leelahavanichkul A, Doi K, Chawla LS, Illei GG, Kopp JB, Balow JE, Austin HA 3rd, Yuen PS, Star RA (2008). Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int, 74(5), 613-21. (Read full article)
- McKenzie LM, Hendrickson SL, Briggs WA, Dart RA, Korbet SM, Mokrzycki MH, Kimmel PL, Ahuja TS, Berns JS, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Cho M, Zhou YC, Binns-Roemer E, Kirk GD, Kopp JB, Winkler CA (2007). NPHS2 variation in sporadic focal segmental glomerulosclerosis. J Am Soc Nephrol, 18(11), 2987-95. (Read full article)
- Cho ME, Smith DC, Branton MH, Penzak SR, Kopp JB (2007). Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis. Clin J Am Soc Nephrol, 2(5), 906-13. (Read full article)
- Cho ME, Hurley JK, Kopp JB (2007). Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicity. Am J Kidney Dis, 49(2), 310-7. (Read full article)
Review
- Cho ME, Beddhu S (2016). Dietary recommendations for patients with nondialysis CKD. [Review].